Author

Matti O. Korhonen

Finnish Red CrossORCID 0000-0002-1573-0458Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Anita LaitineniD· 1 shared Annu LuostarineniD· 1 shared Erja KerkeläiD· 1 shared Farhana JahaniD· 1 shared Heidi HongistoiD· 1 shared Kaarina Lähteenmäki· 1 shared Kim K. VettenrantaiD· 1 shared Laurens Veltman· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anita LaitinenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts

Farhana Jahan, Leena Penna, Annu Luostarinen, Laurens Veltman, Heidi Hongisto, Kaarina Lähteenmäki, Sabine Müller, Seppo Ylä‐Herttuala, Matti O. Korhonen, Kim K. Vettenranta, Anita Laitinen, Urpu Salmenniemi, Erja Kerkelä

This paper describes a GMP-compliant protocol for producing potent NK cells against AML and neuroblastoma using an automated platform, showing increased activation and killing efficacy.

Scientific Reports · Nov 4, 2024Peer-reviewedImmunology